GRITSTONE BIO INC (GRTS)
US39868T1051 - Common Stock
ChartMill assigns a Buy % Consensus number of 80% to GRTS. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 4.08. This target is 7455.56% above the current price.
GRTS was analyzed by 12 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about GRTS.
In the previous month the buy percentage consensus was at a similar level.
GRTS was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-10-02 | Jones Trading | Downgrade | Buy -> Hold |
| 2024-10-02 | B. Riley Securities | Downgrade | Buy -> Neutral |
| 2024-10-01 | JMP Securities | Downgrade | Market Outperform -> Market Perform |
| 2024-10-01 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2024-08-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-05 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-08-05 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-14 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-05-24 | B. Riley Securities | Reiterate | Buy -> Buy |
| 2024-05-13 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-04-02 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2024-03-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-02-28 | JMP Securities | Initiate | Market Outperform |
| 2023-09-28 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-08-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-03-28 | B. Riley Securities | Initiate | Buy |
| 2023-03-14 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-02-15 | HC Wainwright & Co. | Maintains | Buy |
| 2022-11-07 | HC Wainwright & Co. | Maintains | Buy |
| 2022-10-31 | Piper Sandler | Initiate | Overweight |
| 2022-08-22 | Goldman Sachs | Downgrade | Neutral -> Sell |
| 2022-05-09 | HC Wainwright & Co. | Maintains | Buy |